CHONGQING, CHINA - JULY 29: In this photo illustration, a person holds a smartphone displaying the logo of Bristol Myers Squibb Company (NYSE: BMY), a global biopharmaceutical firm focused on oncology ...

Could the pharmaceutical giant turn things around next year? Let's find out whether Bristol Myers Squibb is a buy, sell, or hold heading into 2026.

Bristol-Myers Squibb Company (NYSE:BMY) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 15, ...

Bristol-Myers Squibb (NYSE: BMY) has considerably lagged behind the overall market, with its stock decreasing by 20% this year, while the S&P 500 index has risen by 14%. This drop can be attributed in ...

Bristol Myers Squibb’s efforts to diversify its cancer portfolio beyond immunotherapies brought radiopharmaceuticals to its pipeline. Now it’s expanding its radiopharmaceuticals scope to prostate ...

Bristol Myers Squibb (BMY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Bristol Myers Squibb (BMY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

A fourth wave of layoffs is coming to pharma Bristol Myers Squibb, which is headquartered in the Princeton area. In a filing with the New Jersey Department of Labor & Workforce Development, the ...